Amphastar Pharmaceuticals (AMPH) Cash from Operations (2016 - 2025)
Amphastar Pharmaceuticals has reported Cash from Operations over the past 13 years, most recently at 32863000.0 for Q4 2025.
- Quarterly results put Cash from Operations at 32863000.0 for Q4 2025, up 13.23% from a year ago — trailing twelve months through Dec 2025 was 156115000.0 (down 26.84% YoY), and the annual figure for FY2025 was 156115000.0, down 26.84%.
- Cash from Operations for Q4 2025 was 32863000.0 at Amphastar Pharmaceuticals, down from 52583000.0 in the prior quarter.
- Over the last five years, Cash from Operations for AMPH hit a ceiling of 69109000.0 in Q2 2024 and a floor of 2569000.0 in Q3 2021.
- Median Cash from Operations over the past 5 years was 35334500.0 (2025), compared with a mean of 37008950.0.
- Biggest five-year swings in Cash from Operations: plummeted 91.25% in 2022 and later surged 1851.08% in 2023.
- Amphastar Pharmaceuticals' Cash from Operations stood at 40441000.0 in 2021, then plummeted by 62.35% to 15226000.0 in 2022, then surged by 56.73% to 23864000.0 in 2023, then increased by 21.62% to 29024000.0 in 2024, then rose by 13.23% to 32863000.0 in 2025.
- The last three reported values for Cash from Operations were 32863000.0 (Q4 2025), 52583000.0 (Q3 2025), and 35592000.0 (Q2 2025) per Business Quant data.